Desipramine

Cat. No.: HY-B1272A: Data Sheet Handling Instructions
FAQs
Technical Support

Desipramine is a first-generation tricyclic antidepressant. Desipramine selectively binds to norepinephrine transporter and blocks neuronal norepinephrine reuptake. Desipramine activates MAPK signaling via ERK1/2, JNK, and p38, represses NF-κB and AP-1 activity, and induces apoptosis via ROS elevation, mitochondrial membrane potential reduction, and intracellular calcium increase. Desipramine also shows anyi-inflammatory activity, inhibiting TNF-α production. Desipramine can be used for the research of hepatocellular cancer, inflammation, and neurological diseases.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 50-47-5

사이즈		재고
MOQ		Minimum order quantity
50 mg		견적 받기
100 mg		견적 받기
250 mg		견적 받기
Other size		견적 받기

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Desipramine:

Desipramine hydrochloride

Other Forms of Desipramine:

15 Publications Citing Use of MCE Desipramine

Bio/Physico-chemical Assay

Cell Proliferation/Viability Assay

Cell Imaging/Staining

: Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]; Desipramine hydrochloride (Des; 0-50 μM; 24 h). Cell viability of BRL-3A cells after Des intervention was detected by CCK-8. Other groups were compared with 0 μM group.

: Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]; Desipramine hydrochloride (Des; 12.5 μM; 24 h). The expression levels of apoptosis-related proteins in BRL-3A cells were detected by western blotting.

: Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]; Desipramine hydrochloride (Des; 12.5 μM; 24 h). Hoechst/PI double staining: Hoechst/PI was used to double stain and observe them under fluorescence microscope (200×). Hoechst 33342 can stain the nucleus with blue fluorescence. PI can stain necrotic cells with red fluorescence.

: Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]; Desipramine hydrochloride (Des; 12.5 μM; 24 h). The level of LDH in cell culture medium after 12.5 μM Des intervention and/or 20 μM Cadmium exposure for 24 h.

: Desipramine purchased from MedChemExpress. Usage Cited in: Pharmaceutics. 2022 Jul 22;14(8):1523.; Figure shows that 10 and 30 μM of Desipramine hydrochloride attenuated EGCG-induced enhancement of MNPcell by 8.9% and 39.3% in the Mag− group, respectively. In the Mag+ group, MNPcell was enhanced up to 6.6-fold by EGCG compared with the control group, which was minorly attenuated by 5.7% and 11.2% by Desipramine hydrochloride at 10 and 30 μM, respectively.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Adrenergic Receptor Isoform Specific Products:

View All Isoforms

α adrenergic receptor β adrenergic receptor

View All ERK Isoform Specific Products:

View All Isoforms

ERK ERK1 ERK2 ERK5 ERK8

View All JNK Isoform Specific Products:

View All Isoforms

JNK1 JNK2 JNK3 JNK

View All p38 MAPK Isoform Specific Products:

View All Isoforms

p38 MAPK Akt1 p38α p38β MAPK13 p38δ p38γ

View All NF-κB Isoform Specific Products:

View All Isoforms

NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

View All AP-1 Isoform Specific Products:

View All Isoforms

c-Fos FosB Fra1/FOSL1 Fra2/FOSL2 c-Jun

View All TNF Receptor Isoform Specific Products:

View All Isoforms

TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF10B/DR5/CD262 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

Biological Activity
순도&문서
References
고객리뷰

제품 설명

IC₅₀ & Target^[1]

ERK1

ERK2

Cellular Effect

Cell Line	Type	Value	Description	References
DG-75	IC₅₀	39.81 3 Compound: Desipramine	Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
MDCK	IC₅₀	0.93 1 Compound: desipramine	Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane	[PMID: 16989524]
MDCK	IC₅₀	0.93 1 Compound: desipramine	Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs	[PMID: 23403082]
HEK293	IC₅₀	1520 1 Compound: Desipramine	Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA	[PMID: 21300721]
MDCK	IC₅₀	1.5 1 Compound: Desipramine	Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells	[PMID: 24012181]
DG-75	IC₅₀	39.81 3 Compound: Desipramine	Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
HEK293	IC₅₀	56.8 3 Compound: desipramine	Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy	[PMID: 18788725]
HEK293	IC₅₀	0.0042 3 Compound: Desipramine	Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells	[PMID: 17846138]
HEK293	IC₅₀	9.18 3 Compound: Desipramine	Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay	[PMID: 28230985]
MDCK	IC₅₀	3.9 1 Compound: desipramine	Inhibition of norepinephrine uptake at human NET expressed in MDCK cells Inhibition of norepinephrine uptake at human NET expressed in MDCK cells	[PMID: 18771916]
HEK293	IC₅₀	0.0524 3 Compound: desipramine	Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells	[PMID: 17690258]
HeLa	IC₅₀	17.78 3 Compound: Desipramine	Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
DG-75	IC₅₀	39.81 3 Compound: Desipramine	Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
HEK293	IC₅₀	0.064 3 Compound: Desipramine	Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells	[PMID: 17846138]
MDCK	IC₅₀	0.93 1 Compound: desipramine	Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs	[PMID: 23403082]
HEK293	IC₅₀	0.064 3 Compound: Desipramine	Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells	[PMID: 17846138]
HEK293	IC₅₀	82 3 Compound: Desipramine	Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells	[PMID: 17846138]
HEK293	IC₅₀	0.108 3 Compound: desipramine	Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells	[PMID: 17690258]
Splenocyte	IC₅₀	22.9 3 Compound: Desipramine	Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay	[PMID: 17846138]
HEK293	IC₅₀	1520 1 Compound: Desipramine	Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA	[PMID: 21300721]
HEK293	IC₅₀	9.9 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells	[PMID: 17690258]
Ventricular myocyte	IC₅₀	1.709 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes	[PMID: 22761000]
HEK293	IC₅₀	17.7 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	17.7 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells	[PMID: 17690258]
Ventricular myocyte	IC₅₀	11.7 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes	[PMID: 22761000]
HEK293	IC₅₀	50.5 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells	[PMID: 17690258]
Ventricular myocyte	IC₅₀	1709 1 Compound: Desipramine	Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes	[PMID: 21300721]
HEK293	IC₅₀	47.9 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	47.9 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	50.5 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	56.8 3 Compound: desipramine	Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy	[PMID: 18788725]
HEK293	IC₅₀	0.0042 3 Compound: Desipramine	Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells	[PMID: 17846138]
HEK293	IC₅₀	82 3 Compound: Desipramine	Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells	[PMID: 17846138]
HEK293	IC₅₀	0.0524 3 Compound: desipramine	Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	9.18 3 Compound: Desipramine	Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay	[PMID: 28230985]
HEK293	IC₅₀	0.108 3 Compound: desipramine	Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	9.9 3 Compound: desipramine	Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells	[PMID: 17690258]
HEK293	IC₅₀	56.8 3 Compound: desipramine	Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy	[PMID: 18788725]
HEK293	IC₅₀	9.18 3 Compound: Desipramine	Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay	[PMID: 28230985]
HeLa	IC₅₀	17.78 3 Compound: Desipramine	Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
HEK293	IC₅₀	1520 1 Compound: Desipramine	Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA	[PMID: 21300721]
HRPE	IC₅₀	0.08 2 Compound: Desipramine	TP_TRANSPORTER: inhibition of TEA uptake in Octn1-HRPE cells TP_TRANSPORTER: inhibition of TEA uptake in Octn1-HRPE cells	[PMID: 10825452]
Ventricular myocyte	IC₅₀	1709 1 Compound: Desipramine	Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes	[PMID: 21300721]
HRPE	IC₅₀	68 3 Compound: Desipramine	TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells	[PMID: 9830022]
Splenocyte	IC₅₀	22.9 3 Compound: Desipramine	Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay	[PMID: 17846138]
Ventricular myocyte	IC₅₀	1.709 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes	[PMID: 22761000]
Ventricular myocyte	IC₅₀	11.7 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes	[PMID: 22761000]
HeLa	IC₅₀	17.78 3 Compound: Desipramine	Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay	[PMID: 23385211]
MDCK	IC₅₀	0.93 1 Compound: desipramine	Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane	[PMID: 16989524]
MDCK	IC₅₀	0.93 1 Compound: desipramine	Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs	[PMID: 23403082]
MDCK	IC₅₀	1.5 1 Compound: Desipramine	Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells	[PMID: 24012181]
MDCK	IC₅₀	3.9 1 Compound: desipramine	Inhibition of norepinephrine uptake at human NET expressed in MDCK cells Inhibition of norepinephrine uptake at human NET expressed in MDCK cells	[PMID: 18771916]
Oocyte	IC₅₀	10 3 Compound: Desipramine	TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in Xenopus laevis oocytes TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in Xenopus laevis oocytes	[PMID: 11502595]
Oocyte	IC₅₀	17.5 3 Compound: Desipramine	TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in Xenopus laevis oocytes TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in Xenopus laevis oocytes	[PMID: 11502595]
Splenocyte	IC₅₀	22.9 3 Compound: Desipramine	Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay	[PMID: 17846138]
Ventricular myocyte	IC₅₀	1.709 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes	[PMID: 22761000]
Ventricular myocyte	IC₅₀	11.7 3 Compound: Desipramine	Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes	[PMID: 22761000]
Ventricular myocyte	IC₅₀	1709 1 Compound: Desipramine	Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes	[PMID: 21300721]

In Vitro

Desipramine (3-500 µM; 24 h) reduces the viability of human hepatoma Hep3B cells in a dose-dependent manner^[1].
Desipramine (10-500 µM; 24 h) induces cytotoxicity in human hepatoma Hep3B cells in a dose-dependent manner, as measured by increased LDH release^[1].
Desipramine (3-100 µM; 24 h) increases intracellular ROS production in human hepatoma Hep3B cells in a dose-dependent manner^[1].
Desipramine (3-100 µM µM; 24 h) has its induced cell death in human hepatoma Hep3B cells abolished by the ROS scavenger NAC (HY-B0215) at concentrations up to 30 µM, and partially reduced at 100 µM after 24 h^[1].
Desipramine (3-100 µM; 24 h) reduces mitochondrial membrane potential in human hepatoma Hep3B cells in vitro in a dose-dependent manner^[1].
Desipramine (100 µM; 1-8 h) activates ERK1/2, JNK, and p38 MAPK signaling in human hepatoma Hep3B cells-^[1].
Desipramine (3-100 µM; 24 h) has its induced cell death in human hepatoma Hep3B cells abolished by inhibition of ERK1/2, p38, or JNK MAPK signaling^[1].
Desipramine (30-500 µM) increases intracellular calcium levels in human hepatoma Hep3B cells in a concentration-dependent manner, with increases occurring via both extracellular calcium influx and intracellular calcium release^[1].
Desipramine potently binds to the rat norepinephrine transporter with a K_i of 6.2 nM, showing 25-fold selectivity over the rat serotonin transporter (K_i = 158 nM) ^[3].
Desipramine (1 h) binds to the rat α₂D-adrenoceptor with a K_i of 3.4 μM^[3].
Desipramine potently binds to the human norepinephrine transporter with a K_i of 0.63 nM, has lower affinity for the human serotonin transporter (K_i = 22 nM), and lacks affinity for the human dopamine transporter (K_i > 10,000 nM)^[3].
Desipramine (0.01-10 μM; 20 h) dose-dependently inhibits LPS (HY-D1056)-induced TNF-α release from primary human monocytes^[4].
Desipramine (10 μM) reduces TNF-α-induced RANTES release and RANTES mRNA accumulation in A549 human lung epithelial cells^[4].
Desipramine (10 μM) represses TNF-α-induced NF-κB activity in A549 human lung epithelial cells^[4].
Desipramine (10 μM) reduces TPA (HY-18739)-induced AP-1 activity in A549 human lung epithelial cells^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	human hepatoma Hep3B cells
Concentration:	1 µM, 3 µM, 10 µM, 30 µM, 100 µM, 300 µM, 500 µM
Incubation Time:	24 h
Result:	Did not affect cell viability at 1 µM. Reduced cell viability to 90.2% of control at 3 µM. Reduced cell viability to 87.4% of control at 10 µM. Reduced cell viability to 69.1% of control at 30 µM. Reduced cell viability to 45.9% of control at 100 µM. Reduced cell viability to 36.1% of control at 300 µM. Reduced cell viability to 27.8% of control at 500 µM. Caused statistically significant viability reductions at concentrations ≥3 µM compared to control.

Cell Cytotoxicity Assay^[1]

Cell Line:	human hepatoma Hep3B cells
Concentration:	10 µM, 30 µM, 100 µM, 300 µM, 500 µM
Incubation Time:	24 h
Result:	Increased LDH activity to 105.7% of control at 10 µM. Increased LDH activity to 109.8% of control at 30 µM. Increased LDH activity to 150.3% of control at 100 µM. Increased LDH activity to 227.7% of control at 300 µM. Increased LDH activity to 255.7% of control at 500 µM. Caused statistically significant increases in LDH release at all tested concentrations compared to control.

Western Blot Analysis^[1]

Cell Line:	human hepatoma Hep3B cells
Concentration:	100 µM
Incubation Time:	1 h, 2 h, 4 h, 8 h
Result:	Increased phosphorylation of ERK1/2 to 185.2% of control at 1 h, 151.5% of control at 2 h, and 138.5% of control at 4 h. Increased phosphorylation of p38 to 135.1% of control at 1 h and 116.4% of control at 2 h. Increased phosphorylation of JNK to 118.9% of control at 1 h and 113.9% of control at 2 h. Maintained unchanged total levels of ERK1/2, JNK, and p38 across all time points. Caused statistically significant increases in MAPK phosphorylation at the specified time points compared to control.

In Vivo

Desipramine (5-20 mg/kg; i.p.; single dose, 30 minutes pre-LPS) dose-dependently inhibits LPS (HY-D1056)-induced serum TNF-α production and increases survival rate to 70% in a murine septic shock model^[4].
Desipramine (10 mg/kg; i.p.; daily; 8 days, 30 minutes pre-Ovalbumin nebulization) reduces lung inflammation by decreasing macrophage and lymphocyte counts in Ovalbumin (HY-W250978)-sensitized rats but does not attenuate bronchial hyperresponsiveness^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	LPS-induced BALB/c mice (5-week-old, 17-21 g)^[4]
Dosage:	5, 10, 20 mg/kg
Administration:	i.p.; single dose (preventive, 30 minutes pre-LPS)
Result:	Significantly inhibited LPS-induced serum TNF-α production. Increased mouse survival rate to 70% with preventive 20 mg/kg treatment (vs 10% in saline controls).

Animal Model:	Ovalbumin-sensitized Brown Norway rats (10-week-old)^[4]
Dosage:	10 mg/kg
Administration:	i.p.; daily; 8 days (30 minutes pre-ovalbumin nebulization)
Result:	Did not reduce bronchial hyperresponsiveness to metacholine (measured by enhanced pause, Penh). Reduced total number of inflammatory cells in bronchoalveolar lavages. Decreased macrophage count by 52% compared to saline-treated sensitized rats. Decreased lymphocyte count by 21% compared to saline-treated sensitized rats. Did not reduce neutrophil or eosinophil counts compared to saline-treated sensitized rats.

분자량

266.38

화학식

C₁₈H₂₂N₂

CAS No.

50-47-5

SMILES

CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31

선적

Room temperature in continental US; may vary elsewhere.

보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Yang DK, et al. Desipramine induces apoptosis in hepatocellular carcinoma cells. Oncol Rep. 2017;38(2):1029-1034.

[2]. Kishore-Kumar R, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47(3):305-312.

[3]. Deupree JD, et al. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. Eur J Pharmacol. 2007;576(1-3):55-60.

[4]. Roumestan C, et al. Anti-inflammatory properties of desipramine and fluoxetine. Respir Res. 2007;8(1):35. Published 2007 May 3.

Desipramine Related Classifications

몰농도 계산기
농도 희석 계산기

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass		Concentration		Volume		Molecular Weight *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)	×	Volume _(start)	=	Concentration _(final)	×	Volume _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Please select a local distributor ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
상품명			Requested Quantity *
고객명 *			호칭
메일주소 *			전화번호 *
Department			회사명 *
City			도
Country or Region *
비고

상품명			Lot #
고객명 *			메일주소 *
전화번호			Department *
회사명 *			Country or Region *
비고

Desipramine

Other Forms of Desipramine:

15 Publications Citing Use of MCE Desipramine

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Adrenergic Receptor Isoform Specific Products:

View All ERK Isoform Specific Products:

View All JNK Isoform Specific Products:

View All p38 MAPK Isoform Specific Products:

View All NF-κB Isoform Specific Products:

View All AP-1 Isoform Specific Products:

View All TNF Receptor Isoform Specific Products:

Biological Activity

순도&문서

References

고객리뷰

Desipramine Related Classifications

몰농도 계산기

농도 희석 계산기

The molarity calculator equation

The dilution calculator equation

Keywords:

최근 본 상품:

Name
이메일 *

	Sorry, but the email address you supplied was invalid.

Desipramine

Other Forms of Desipramine:

Desipramine Related Antibodies

15 Publications Citing Use of MCE Desipramine

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Adrenergic Receptor Isoform Specific Products:

View All ERK Isoform Specific Products:

View All JNK Isoform Specific Products:

View All p38 MAPK Isoform Specific Products:

View All NF-κB Isoform Specific Products:

View All AP-1 Isoform Specific Products:

View All TNF Receptor Isoform Specific Products:

Biological Activity

순도&문서

References

고객리뷰

Desipramine Related Antibodies

Desipramine Related Classifications

몰농도 계산기

농도 희석 계산기

The molarity calculator equation

The dilution calculator equation

Keywords:

최근 본 상품:

고객리뷰

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report